Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatocellular Carcinoma Imaging Using PSMA PET/CT
NCT05095519Phase 2Completed
- Sponsor
- Peter MacCallum Cancer Centre
- Start
- Sep 2021
- Primary completion
- May 2026
- Countries
- 1
01
Overview
A Phase 2 trial of piflufolastat f 18 in hepatocellular carcinoma (HCC), sponsored by Peter MacCallum Cancer Centre. Started Sep 2021; status: completed.
02
Drugs
piflufolastat f 18
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT05095519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05095519.